Skip to main content

Advertisement

SpringerLink
Log in

Terms of agreement between the Austrian Society of Cardiology and the Austrian Society of Thoracic and Cardiovascular Surgery on transcatheter heart valve interventions*

  • Position Paper
  • Published:
European Surgery Aims and scope Submit manuscript

Summary

BACKGROUND: Due to the increasing volume of transcatheter heart valve interventions, we place on record the terms of the agreement reached between the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Thoracic and Cardiovascular Surgery (ÖGTHC) regarding these procedures as follows. METHODS: The paper is based on the guidelines of the European societies, a review of the PubMed literature, as well as information from the medical industry. RESULTS: Currently, transcatheter-based aortic and pulmonary implantation are performed as well as transcatheter-based procedures for mitral valve insufficiency. In all cases the indication should be decided jointly by the cardiologist and the cardiac surgeon. Furthermore, these procedures should only be performed in centres where both specialists are available on site. Only patients with either congenital or acquired heart valve disease who are at very high risk of morbidity and mortality with medical or standard surgical therapy should undergo transcatheter heart valve intervention. CONCLUSIONS: According to current literature, recommendations for transcatheter heart valve interventions are only based on level of Evidence C (Consensus of Expert Opinion).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006–8

    Article  PubMed  Google Scholar 

  • Sack S, Kahlert P, Khandanpour S, et al. Aortic valve stenosis: from valvuloplasty to percutaneous heart valve. Herz 2006;31:688–93

    Article  PubMed  Google Scholar 

  • Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698–703

    Article  PubMed  Google Scholar 

  • Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214–23

    Article  PubMed  Google Scholar 

  • Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high risk patients with aortic valve disease. The Siegburg first-in-man study. Circulation 2006;114:1616–24

    Article  PubMed  Google Scholar 

  • Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006;114:591–6

    Article  PubMed  Google Scholar 

  • Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high risk patients using the second- and current third-generation self-expanding CoreValve prosthesis. Device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69–76

    Article  PubMed  Google Scholar 

  • Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755–63

    Article  PubMed  Google Scholar 

  • Walther T, Falk V, Borger MA, et al. Minimally invasive transapical beating heart aortic valve implantation – proof of concept. Eur J Cardiothorac Surg 2007;31:9–15

    Article  PubMed  Google Scholar 

  • Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;116(Suppl-I):I240–5

    PubMed  Google Scholar 

  • Walther T, Falk V, Kempfert J, et al. Transapical minimally invasive aortic valve implantation – the initial 50 patients. Eur J Cardiothorac Surg 2008;33:983–8

    Article  PubMed  Google Scholar 

  • Svensson LG, Dewey T, Kapadia S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008;86(1):46–54, discussion 54–5

    Article  PubMed  Google Scholar 

  • Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve ReValving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroInterv 2008;4:242–9

    Article  Google Scholar 

  • Walther T, Dewey T, Borger MA, et al. Transapical aortic valve implantation (TA-AVI): step by step. Ann Thorac Surg 2009;87:276–83

    Article  PubMed  Google Scholar 

  • Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;29:1463–70

    Article  PubMed  Google Scholar 

  • Vassiliades TA, Block PC, Cohn LH, et al. The clinical development of percutaneous heart valve technology. J Am Coll Cardiol 2005;45:1554–60

    Article  PubMed  Google Scholar 

  • Gummert JF, Funkat A, Beckmann A, et al. Cardiac surgery in Germany during 2007; a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2008;56:328–36

    Article  PubMed  CAS  Google Scholar 

  • Kahlert P, Eggebrecht H, Erbel R, et al. A modified "preclosure" technique after percutaneous aortic valve replacement. Cath Cardiovasc Interv 2008;72:877–84

    Article  Google Scholar 

  • Behan M, Haworth P, Hutchinson N, et al. Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv 2008;72:1012–5

    Article  PubMed  Google Scholar 

  • Berry C, Asgar A, Lamarche Y, et al. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc Interv 2007;70:610–6

    Article  PubMed  Google Scholar 

  • De Jaegere PP, Piazza N, Galema TW, et al. Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve Revalving System aortic valve bioprosthesis. EuroIntervention 2008;4:351–7

    Article  PubMed  Google Scholar 

  • Tamburino C, Capodanno D, Mulè M, et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 2009;21:93–8

    PubMed  Google Scholar 

  • Gerckens U, Latsios G, Mueller R, et al. Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (inseries) CoreValve prostheses in 1 procedure. JACC Cardiovasc Interv 2010;3:244–50

    Article  PubMed  Google Scholar 

  • Ludman PF. The UK TAVI registry. EuroPCR 2010 25 May 2010–28 May 2010, Paris–France

  • Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010;3:359–66

    Article  PubMed  Google Scholar 

  • Thomas M, Schymik G, Walther T, et al. Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry. Circulation 2010;122:62–9

    Article  PubMed  Google Scholar 

  • Ye J, Cheung A, Lichtenstein SV, et al. Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg 2010;139:1107–13, 1113.e1

    Article  PubMed  Google Scholar 

  • Ferrari E, Sulzer C, Marcucci C, et al. Transapical aortic valve implantation without angiography: proof of concept. Ann Thorac Surg 2010;89:1932–3

    Article  Google Scholar 

  • Walther T, Schuler G, Borger MA, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J 2010;31:1398–403

    Article  PubMed  Google Scholar 

  • De Bruyne B, et al. Medium term survival and functional status in patients with severe aortic stenosis treated by transcatheter aortic valvular implantation in the PARTNER EU trial. The 21st Annual Scientific Sessions Transcatheter Cardiovascular Therapeutics, September 21–25, 2009, San Francisco, California

  • Thomas M. Update from the SOURCE Registry. EuroPCR, 25 May 2010–28 May 2010, Paris–France

  • Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. J Am Coll Cardiol 2010;55:1080–90

    Article  PubMed  Google Scholar 

  • Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356(9239):1403–5

    Article  PubMed  CAS  Google Scholar 

  • Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: Results in 59 consecutive patients. Circulation 2005;112:1189–97

    Article  PubMed  Google Scholar 

  • Peng LF, McElhinney DB, Nugent AW, et al. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience. Circulation 2006;113:2598–605

    Article  PubMed  Google Scholar 

  • Powell AJ, Lock JE, Keane JF, et al. Prolongation of RV-PA conduit life span by percutaneous stent implantation: intermediate-term results. Circulation 1995;92:3282–8

    PubMed  CAS  Google Scholar 

  • Fogelman R, Nykanen D, Smallhorn JF, et al. Endovascular stents in the pulmonary circulation: clinical impact on management and medium-term follow-up. Circulation 1995;92:881–5

    PubMed  CAS  Google Scholar 

  • Kanter KR, Budde JM, Parks WJ, et al. One hundred pulmonary valve replacements in children after relief of right ventricular outflow tract obstruction. Ann Thorac Surg 2002;73:1801–6

    Article  PubMed  Google Scholar 

  • Bielefeld MR, Bishop DA, Campbell DN, et al. Reoperative homograft right ventricular outflow tract reconstruction. Ann Thorac Surg 2001;71:482–7

    Article  PubMed  CAS  Google Scholar 

  • Horer J, Stierle U, Bogers AJ, et al. Re-interventions on the autograft and the homograft after the Ross operation in children. Eur J Cardiothorac Surg 2010;37:1008–14

    Article  PubMed  Google Scholar 

  • Askovich B, Hawkins JA, Sower CT, et al. Right ventricle-topulmonary artery conduit longevity: is it related to allograft size? Ann Thorac Surg 2007;84:907–11

    Article  PubMed  Google Scholar 

  • Brown JW, Ruzmetov M, Rodefeld MD, et al. Right ventricular outflow tract reconstruction with an allograft conduit in non-Ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg 2005;80:655–63

    Article  PubMed  Google Scholar 

  • Stark J, Bull C, Stajevic M, et al. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg 1998;115:506–14

    Article  PubMed  CAS  Google Scholar 

  • Tweddell JS, Pelech AN, Frommelt PC, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 2000;102 (Suppl III):III-130–5

    CAS  Google Scholar 

  • Oosterhof T, Meijboom FJ, Vliegen HW, et al. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006;27:1478–84

    Article  PubMed  Google Scholar 

  • Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356:1403–5

    Article  PubMed  CAS  Google Scholar 

  • Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005;112:1189–97

    Article  PubMed  Google Scholar 

  • Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008;117:1964–72

    Article  PubMed  Google Scholar 

  • Boone RH, Webb JG, Horlick E, et al. Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc Interv 2010;75:286–94

    Article  PubMed  Google Scholar 

  • Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46:2134–40

    Article  PubMed  Google Scholar 

  • Foster E, Wasserman HS, Gray W, et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007;100:1577–83

    Article  PubMed  Google Scholar 

  • Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686–94

    Article  PubMed  Google Scholar 

  • Herrmann HC, Kar S, Siegel R, Fail P, Loghin C, Lim S, Hahn R, Rogers JH, Bommer WJ, Wang A, Berke A, Lerakis S, Kramer P, Wong SC, Foster E, Glower D, Feldman T. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient; EuroIntervention 2008;4:437–42

    Article  Google Scholar 

  • Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–607

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Task force comprising the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Thoracic and Cardiovascular Society (ÖGTHC), Austria

    W. Wisser (Chairman), H. Gabriel, H. Mächler, R. Maier, E. Maurer, L. Müller & T. Neunteufl

Authors
  1. W. Wisser (Chairman)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Gabriel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Mächler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Neunteufl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Wisser (Chairman).

Additional information

*: A tribute to Wolfgang Wayand, Head of Department, 1 January 1985–31 March 2012, Department of Surgery II, General Hospital Linz, Linz, Austria

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wisser (Chairman), W., Gabriel, H., Mächler, H. et al. Terms of agreement between the Austrian Society of Cardiology and the Austrian Society of Thoracic and Cardiovascular Surgery on transcatheter heart valve interventions* . Eur Surg 44, 33–40 (2012). https://doi.org/10.1007/s10353-011-0066-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10353-011-0066-3

Keywords

Search

Navigation